New Research Shows COVID-19 Vaccines Protect Heart Health

New research offers fresh evidence that staying up to date with COVID-19 vaccinations can do more than just prevent respiratory illness. According to studies recently published in JAMA Internal Medicine, the latest COVID-19 vaccines provide significant protection against major heart-related problems. This is especially true for older adults and those with existing health conditions.

For many people, the COVID-19 pandemic feels like a distant memory, and fewer people are choosing to get the updated seasonal shots. However, health experts continue to study how these vaccines affect the body over time. A large study led by Ziyad Al-Aly of the VA St. Louis Health Care System examined data from over one million veterans. The researchers compared people who received the 2024–2025 COVID-19 vaccine with those who only received a flu shot. The goal was to see if the COVID-19 vaccine helped prevent what doctors call "major adverse cardiovascular events" (MACE). This term refers to serious heart issues, including heart attacks, strokes, heart failure, and death caused by heart problems.

According to Ars Technica, the study found that the vaccine was about 38 percent effective at preventing these serious heart events linked to COVID-19. While the researchers noted that the overall benefit might seem modest in terms of raw numbers, it is still a meaningful improvement for public health. Specifically, the study estimated that the vaccines lowered the rate of these heart events from about 5 in 10,000 people to 3 in 10,000.

One of the most important findings from the research was the difference in results based on age. The protective effect against heart problems was strongest in people older than 75. In this group, the vaccine provided a clear reduction in the risk of severe outcomes. MedPage Today reported that for these older adults, the vaccine was roughly 50 percent effective at preventing heart-related complications associated with the virus. This suggests that even as the virus changes, the vaccines continue to offer a layer of safety for the most vulnerable members of society.

Beyond heart health, other research published in the same medical journal looked at how well the 2024–2025 vaccines protected against general COVID-19 illness. Ryan Wiegand, a researcher at the CDC, led a team that examined how well the shots prevented emergency room visits, hospital stays, and critical illness. Their findings showed that the vaccines were 35 percent effective at preventing hospitalizations and 41 percent effective at preventing critical illness among adults. These benefits were found to be especially helpful in the first six months after receiving the vaccine.

Why does this matter now? The virus that causes COVID-19 has evolved since the start of the pandemic, and many people have developed some level of immunity through past infections or previous shots. Because of this, some might wonder if the vaccines are still necessary. However, the researchers emphasized that vaccination remains a key way to reduce the risk of severe health outcomes. Al-Aly and his colleagues noted that while the level of protection is not as high as it was during the early days of the vaccine rollout, the shots still provide a clear and measurable benefit.

For doctors and patients, these results provide a clear message. Practicing clinicians often look for ways to help patients avoid the most dangerous effects of the virus. According to the report by Wiegand and his team, these findings confirm that annual vaccination continues to meaningfully reduce the risk of severe illness, particularly for patients who are at the highest risk.

As public health officials look toward the future, the focus remains on keeping people safe from the long-term effects of the virus. While the decision to get vaccinated is a personal one, the data suggests that for older adults and those with underlying health issues, the updated shots offer a proven way to protect the heart and the body. By reducing the chances of hospitalization and serious heart complications, these vaccines continue to play a vital role in healthcare, even as the world moves past the emergency phase of the pandemic.